Skip to Content

M RE4 (Ropinirole Hydrochloride Extended-Release 4 mg)

Pill with imprint M RE4 is Brown, Round and has been identified as Ropinirole Hydrochloride Extended-Release 4 mg. It is supplied by Mylan Pharmaceuticals Inc..

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M RE4

Ropinirole Hydrochloride Extended-Release

Imprint:
M RE4
Strength:
4 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-4091

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide